|
|
The Michelson Prizes: Next Generation Grants are $150,000 research grants given annually to support promising researchers who are applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery and immunotherapy research for major global diseases.
The 2021 Michelson Prizes will be looking for research proposals in two areas:
1. Human Immunology and Vaccine Research
2. Climate Change and Human Immunology
| |
Changes required for personal mobile devices accessing VUMC data
In support of the broader ExpeditionTech Program, VUMC IT is initiating a migration to Microsoft Mobile Application Management (MAM) and Mobile Device Management (MDM) to protect data in Microsoft 365 Apps such as Outlook Email and calendaring. Workforce members who want to access VUMC resources from a personal device will need to take action when communications arrive to ensure a smooth transition.
The staggered rollout has already begun and ends July 1, 2021. See the migration schedule to identify when your group is slotted to begin and visit the Microsoft Mobile (BYOD) website for detailed information.
| |
Updated COVID-19 infection prevention guidance for outdoor and non-clinical areasAs of May 26, VUMC no longer requires employees or visitors to wear masks outside its facilities regardless of the individual’s vaccine status. This change is part of the Medical Center’s updated COVID-19 infection prevention guidance that will be phased between May 26 and June 1.
The updated guidance includes changes to indoor and outdoor masking policies and provides a new ID badge sticker process so that VUMC employees who have been vaccinated for COVID-19 can be easily identified. Beginning June 1, employees who have been vaccinated will no longer be required to mask indoors in non-clinical areas (including non-patient care areas of mixed-use buildings) outlined in the updated guidance. Information about which buildings and areas of buildings on VUMC’s campuses are considered non-clinical is available here.
The updated guidance also includes changes to social/physical distancing requirements, updated guidance on meetings/gatherings, information about changes to the daily temperature screening process at facility entrances, masking requirements in breakrooms, and updated guidance on business travel. Policies for those working from home are not changing at this time.
The guidance for clinical areas and patient encounters has not changed. Masking will continue to be required of all persons, employees and visitors, regardless of their vaccination status, upon entry into all clinical areas. Clinical areas include any patient care or public areas where patients are or may be present. Masking will continue to be required when riding a VUMC shuttle, regardless of an individual’s vaccination status. Visitation policies for hospitals and clinics remain unchanged for now.
Beginning June 1, the Occupational Health Clinic will lead an ID badge sticker process that will allow employees to voluntarily self-identify whether they have been fully vaccinated. Employees who are fully vaccinated can be verified through Occupational Health and will be able to forego masking in non-clinical settings. Employees can consider themselves fully vaccinated 14 days after receiving a 2-shot series (Pfizer or Moderna) or 14 days after a single dose of Johnson and Johnson.
Individuals at VUMC eligible to receive a “Vaccinated” ID badge sticker include employees, volunteers, medical and nursing students, Vanderbilt University employees working in Medical Center facilities, and post-doctoral researchers or fellows.
Frequently Asked Questions (FAQs) about the new masking guidance, “vaccinated” ID badge sticker process, in-person meeting guidance, business travel, and working from home can be found here.
| |
Safety Reminder!Remember to practice good safety habits and lock up unattended valuables as well as lab doors.
| |
UPDATE: Biowaste CollectionThe autoclaves used to process biohazardous waste from the hospital and research labs in VUMC buildings have been removed and replaced with a new Sani-Pak autoclave system. The new system has many advantages over the old system including a safer, more ergonomic process for collection personnel, more efficiency, and more throughput. Starting the week of April 5th, SOM EVS will begin the transition from the current biohazardous waste procedure to the new Sani-Pak procedure.
Here is what this means for you:
- 96-gallon Sani-Pak Collection Carts are being placed in centralized areas, such as autoclave rooms or common equipment areas. There will be future communication with the exact location of the collection point for your lab space once everything is in place.
- When the Collection Points are operational, lab personnel will take their sealed biohazardous waste bags to the Collection Carts and place them inside for disposal. SOM EVS will then take the Carts to the Sani-Pak autoclave for processing and place a new Cart in the centralized area.
- Sharps containers will NOT be placed in the Sani-Pak bins. Sharps containers should be sealed and placed by regular trash containers.
- Once a Sani-Pak Collection Point has been established in your area and sufficient time has passed to ensure that the new process is working smoothly, direct pick-ups of non-sharp biohazardous waste from laboratory spaces will stop.
PLEASE REMEMBER:
- When transporting biohazardous waste, a secondary container is required.
- All bags MUST be closed with a single knot or two zip ties.
- A cart that holds the secondary container is strongly recommended.
- Proper PPE should be used during the transport of biohazardous waste.
- Sharps containers are NOT part of the Sani-Pak system! Those containers must be sealed properly and staged next to your regular trash. They will be processed separately.
| |
Emergency Use Ultra Low FreezerThere is an ultra low freezer for emergency use available to the department. If a laboratory has a freezer failing they can contact Starr and Stephanie to sign out the freezer and to gain access!
| |
| Don't forget - PMI is on Twitter!
| |
Reminder: Zoom meetings should have passwords!
| |
|
|
The Division Congratulations to participating faculty who contributed to 34 publications, posted on PubMed last month!
Business Meeting &Chalk Talk June 29thJohn Karijolich
| |
|
| Tuesdays at 10:30 am on Zoom.
- June 8 - Michael T. Laub, PhD
Professor of Biology
Massachusetts Institute of Technology
| |
Virtual MHI Journal Club Meeting June 2nd & 16th at 9am!
| |
| Thursdays at 1:00 pm on Zoom.
- June 3 - Michelle Wiebe (Hadjifrangiskou Lab)
- June 10 - Jay Jerome (PI)
- June 17 - Taylor Engdahl (Crowe)
- June 24 - Darren Heintzman & Grant Nation (Rathmell & Pua Labs)
| |
|
Fridays at Noon on Zoom.
- June 4 - Ali Nazmi (Olivares-Villagomez Lab)
- June 11 - Jenna Petronglo (Cassat Lab)
- June 18 - Megan Erwin (Philip Lab)
- June 25 - Maggie McBride (Sherwood Lab)
| |
|
MP faculty publications: May 2021 - Lo CT, Abraham A, Lipworth L, Aronoff DM
Am J Reprod Immunol. 2021 May 30:e13476 - Rothamel K, Arcos S, Kim B, Reasoner C, Lisy S, Mukherjee N, Ascano M
Cell Rep. 2021 May 25;35(8):109178 - Itoh T, Hatano R, Horimoto Y, Yamada T, Song D, Otsuka H, Shirakawa Y, Mastuoka S, Iwao N, Aune TM, Dang NH, Kaneko Y, Okumura K, Morimoto C, Ohnuma K
Cell Death Dis. 2021 May 21;12(6):520 - Crooke PS 3rd, Tossberg JT, Porter KP, Aune TM
Curr Res Immunol. 2021;2:52-59 - Werner LR, Gibson KA, Goodman ML, Helm DE, Walter KR, Holloran SM, Trinca GM, Hastings RC, Yang HH, Hu Y, Wei J, Lei G, Yang XY, Madan R, Molinolo AA, Markiewicz MA, Chalise P, Axelrod ML, Balko JM, Hunter KW, Hartman ZC, Lange CA, Hagan CR
J Immunother Cancer. 2021 May;9(5):e001710 - Meegan JE, Bastarache JA, Ware LB
Am J Physiol Lung Cell Mol Physiol. 2021 May 19 - Hernandez A, Patil NK, Bohannon JK
Methods Mol Biol. 2021;2321:111-120 - Boothby MR, Raybuck A, Cho SH, Stengel KR, Haase VH, Hiebert S, Li J
Front Immunol. 2021 May 10;12:664249 - Kaur R, Shropshire JD, Cross KL, Leigh B, Mansueto AJ, Stewart V, Bordenstein SR, Bordenstein SR
Cell Host Microbe. 2021 Apr 27:S1931-3128(21)00134-7 - Baker LX, Grilletta E, Zwerner JP, Boyd AS, Wheless L
Am J Dermatopathol. 2021 May 17 - Wilfong EM, Young-Glazer JJ, Sohn BK, Schroeder G, Annapureddy N, Gillaspie EA, Barnado A, Crofford LJ, Dudenhofer RB
Respir Med. 2021 May 4:106432 - Hannan MT, Crofford LJ
Arthritis Care Res (Hoboken). 2021 May 10 - Segerstrom SC, Blevins TR, Leger KA, Reed RG, Crofford LJ
Collabra Psychol. 2021;7(1):21433 - Engdahl TB, Kuzmina NA, Ronk AJ, Mire CE, Hyde MA, Kose N, Josleyn MD, Sutton RE, Mehta A, Wolters RM, Lloyd NM, Valdivieso FR, Ksiazek TG, Hooper JW, Bukreyev A, Crowe JE Jr
Cell Rep. 2021 May 4;35(5):109086 - Chen EC, Gilchuk P, Zost SJ, Suryadevara N, Winkler ES, Cabel CR, Binshtein E, Sutton RE, Rodriguez J, Day S, Myers L, Trivette A, Williams JK, Davidson E, Li S, Doranz BJ, Campos SK, Carnahan RH, Thorne CA, Diamond MS, Crowe JE
bioRxiv [Preprint]. 2021 May 3:2021.05.02.442326 - Shiakolas AR, Kramer KJ, Wrapp D, Richardson SI, Schäfer A, Wall S, Wang N, Janowska K, Pilewski KA, Venkat R, Parks R, Manamela NP, Raju N, Fechter EF, Holt CM, Suryadevara N, Chen RE, Martinez DR, Nargi RS, Sutton RE, Ledgerwood JE, Graham BS, Diamond MS, Haynes BF, Acharya P, Carnahan RH, Crowe JE Jr, Baric RS, Morris L, McLellan JS, Georgiev IS
Cell Rep Med. 2021 May 21:100313 - Manansala M, Chopra A, Baughman RP, Novak R, Lower EE, Culver DA, Korsten P, Drake WP, Judson MA, Sweiss N
Front Med (Lausanne). 2021 Apr 30;8:672028 - Decloedt EH, Sinxadi PZ, Wiesner L, Joska JA, Haas DW, Maartens G
South Afr J HIV Med. 2021 Apr 28;22(1):1206 - Myers HF, Fair AM, Villalta F, Walz K, Beech BM, Scott WK, Haas DW
Health Equity. 2021 May 13;5(1):288-298 - Gauthier P, Helderman JH
J Am Soc Nephrol. 2000 Oct;11(10):1933-1936 - Niitsu H, Lu Y, Huh WJ, Love AM, Franklin JL, Coffey RJ
Cell Mol Gastroenterol Hepatol. 2021 May 11:S2352-345X(21)00093-X - Khan A, Arias CA, Abbott A, Dien Bard J, Bhatti MM, Humphries RM
J Clin Microbiol. 2021 May 19:JCM.00654-21 - MacVane SH, Bhalodi AA, Dare RK, Rosenbaum ER, Wolfe K, Ford B, Ince D, Kinn P, Percival KM, Humphries RM
J Antimicrob Chemother. 2021 May 22:dkab165 - Tamma PD, Humphries RM
JAC Antimicrob Resist. 2021 May 7;3(2):dlab019 - Reisman BJ, Barone SM, Bachmann BO, Irish JM
Cytometry A. 2021 May 7 - Obradovic A, Chowdhury N, Haake SM, Ager C, Wang V, Vlahos L, Guo XV, Aggen DH, Rathmell WK, Jonasch E, Johnson JE, Roth M, Beckermann KE, Rini BI, McKiernan J, Califano A, Drake CG
Cell. 2021 May 13:S0092-8674(21)00573-0 - Gregory JM, Slaughter JC, Duffus SH, Smith TJ, LeStourgeon LM, Jaser SS, McCoy AB, Luther JM, Giovannetti ER, Boeder S, Pettus JH, Moore DJ
Diabetes Care. 2021 May;44(5):e103-e104 - Toki S, Newcomb DC, Printz RL, Cahill KN, Boyd KL, Niswender KD, Peebles RS Jr
Allergy. 2021 May 6. doi: 10.1111/all.14879 - Shah SC, Peek RM Jr
Gastrointest Endosc Clin N Am. 2021 Jul;31(3):519-542 - Shibao C, Joos K, Phillips JA 3rd, Cogan J, Newman JH, Hamid R, Meiler J, Capra J, Sheehan J, Vetrini F, Yang Y, Black B, Diedrich A, Roberston D, Biaggioni I
Neurology. 2021 May 4:10.1212/WNL.0000000000012143 - Rollins-Smith LA, Le Sage EH
Curr Opin Microbiol. 2021 May 4;61:124-132 - Beavers WN, DuMont AL, Monteith AJ, Maloney KN, Tallman KA, Weiss A, Christian AH, Toste FD, Chang CJ, Porter NA, Torres VJ, Skaar EP
Infect Immun. 2021 May 17:IAI.00146-21 - Yang G, Postoak JL, Song W, Martinez J, Zhang J, Wu L, Van Kaer L
Autophagy. 2021 May 7:1-10 - Wick KD, Leligdowicz A, Zhuo H, Ware LB, Matthay MA
JCI Insight. 2021 May 11:148983
| |
|
|
|
|
